Clinical Trial Update: Study of Talabostat in Advanced Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of talabostat in advanced melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Skin Cancer

Drugs mentioned

• Talabostat (talabostat)

Snippet

Sponsor: Point Therapeutics | Conditions: Melanoma, Skin Cancer | Phase 2 | Status: COMPLETED